ProShare Advisors’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $68.1K | Sell |
|
|||||
|
2025
Q1 | $61.3K | Sell |
|
|||||
|
2024
Q4 | $86.2K | Buy |
|
|||||
|
2024
Q3 | $65.6K | Buy |
|
|||||
|
2024
Q2 | $51.2K | Sell |
|
|||||
|
2024
Q1 | $79.5K | Buy |
|
|||||
|
2023
Q4 | $55K | Buy |
|
|||||
|
2023
Q3 | $46.2K | Buy |
|
|||||
|
2023
Q2 | $57.5K | Buy |
|
|||||
|
2023
Q1 | $49.4K | Sell |
|
|||||
|
2022
Q4 | $80.4K | Buy |
|
|||||
|
2022
Q3 | $88K | Buy |
|
|||||
|
2022
Q2 | $108K | Sell |
|
|||||
|
2022
Q1 | $150K | Sell |
|
|||||
|
2021
Q4 | $231K | Buy |
|
|||||
|
2021
Q3 | $290K | Sell |
|
|||||
|
2021
Q2 | $370K | Buy |
|
|||||
|
2021
Q1 | $254K | Buy |
|